- Home
- VSA vs IMNN Comparison
VSA vs IMNN Comparison
Compare VSA & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSA
- IMNN
- Stock Information
- Founded
- VSA 2002
- IMNN 1982
- Country
- VSA China
- IMNN United States
- Employees
- VSA N/A
- IMNN N/A
- Industry
- VSA
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- VSA
- IMNN Health Care
- Exchange
- VSA NYSE
- IMNN Nasdaq
- Market Cap
- VSA 12.6M
- IMNN 12.1M
- IPO Year
- VSA N/A
- IMNN 1985
- Fundamental
- Price
- VSA $1.27
- IMNN $7.85
- Analyst Decision
- VSA
- IMNN Buy
- Analyst Count
- VSA 0
- IMNN 2
- Target Price
- VSA N/A
- IMNN $210.00
- AVG Volume (30 Days)
- VSA 209.8K
- IMNN 292.8K
- Earning Date
- VSA 08-21-2025
- IMNN 08-05-2025
- Dividend Yield
- VSA N/A
- IMNN N/A
- EPS Growth
- VSA N/A
- IMNN N/A
- EPS
- VSA N/A
- IMNN N/A
- Revenue
- VSA $160,411,283.00
- IMNN N/A
- Revenue This Year
- VSA N/A
- IMNN N/A
- Revenue Next Year
- VSA N/A
- IMNN N/A
- P/E Ratio
- VSA N/A
- IMNN N/A
- Revenue Growth
- VSA N/A
- IMNN N/A
- 52 Week Low
- VSA $0.18
- IMNN $5.55
- 52 Week High
- VSA $2.09
- IMNN $54.75
- Technical
- Relative Strength Index (RSI)
- VSA N/A
- IMNN 39.49
- Support Level
- VSA N/A
- IMNN $6.51
- Resistance Level
- VSA N/A
- IMNN $8.10
- Average True Range (ATR)
- VSA 0.00
- IMNN 1.27
- MACD
- VSA 0.00
- IMNN 0.17
- Stochastic Oscillator
- VSA 0.00
- IMNN 24.41
About VSA TCTM KIDS IT EDUCATION INC SPON ADS EA REP 5 ORD SHS(POST REV SPLT)
TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has two operating segments: the IT Professional Education segment and the IT-focused Supplementary STEM Education Services segment. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).